Medicare Enrolled
Dr. Padraic McCahill, M.D.
Urology Physician · North Easton, MA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. McCahill from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. McCahill?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. McCahill
Dr. Padraic McCahill is an urology physician in North Easton, MA, with 21 years of NPI registration. Based on federal Medicare data, Dr. McCahill performed 9,322 Medicare services across 3,237 unique beneficiaries.
Between the years covered by Open Payments, Dr. McCahill received a total of $9,498 from 66 pharmaceutical and/or device companies across 400 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. McCahill is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ Top 7% volume in MA
$9,498 industry payments
Medicare Practice Summary
Medicare Utilization ↗9,322
Medicare services
Top 7% in MA for urology physician
3,237
Unique beneficiaries
$36
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~444 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
2,171 | $34 | $85 |
| BCG treatment for bladder cancer | 2,101 | $2 | $10 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
1,280 | $2 | $20 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,098 | $95 | $350 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
468 | $9 | $50 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
332 | $68 | $245 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
275 | $50 | $251 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
167 | $34 | $85 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
167 | $34 | $85 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
162 | $128 | $479 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
148 | $190 | $725 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
142 | $8 | $25 |
| PSA test (prostate cancer screening) | 132 | $18 | $100 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
125 | $49 | $85 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 105 | $134 | $750 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
79 | $50 | $300 |
| Nucleic acid test for multiple organisms A laboratory test that uses amplified probe techniques to detect the genetic material of multiple organisms in a sample. |
69 | $69 | $175 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
43 | $74 | $450 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
33 | $37 | $85 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
28 | $12 | $90 |
| Free PSA test A blood test that measures the amount of unbound prostate-specific antigen in the blood. |
26 | $17 | $100 |
| Injection, garamycin, gentamicin, up to 80 mg | 23 | $2 | $15 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
22 | $58 | $289 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
19 | $68 | $264 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
18 | $25 | $89 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
18 | $82 | $300 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
18 | $102 | $375 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
14 | $5 | $20 |
| Blood urea nitrogen test A blood test that measures the amount of urea nitrogen to assess kidney function. |
14 | $4 | $15 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
14 | $44 | $150 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
11 | $197 | $800 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$9,498
Total received (2018-2024)
Avg $1,357/year across 7 years
Top 17% in MA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
66
Companies
400
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,153 (96.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$180 (1.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$164 (1.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,805
2023
$1,225
2022
$1,716
2021
$1,270
2020
$650
2019
$990
2018
$1,842
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Teleflex LLC
$184
Tolmar, Inc.
$143
Sumitomo Pharma America, Inc.
$127
UROGEN PHARMA, INC.
$99
Ferring Pharmaceuticals Inc.
$95
Myriad Genetic Laboratories, Inc.
$93
COLOPLAST CORP
$84
Endo USA, Inc.
$79
ABC Home Medical Supply, Inc.
$75
ACCORD HEALTHCARE, INC.
$70
Laborie Medical Technologies Corp.
$66
ABBVIE INC.
$65
IMMUNITYBIO, INC.
$59
PFIZER INC.
$58
180 Medical, Inc.
$57
Hollister Incorporated
$50
PROGENICS PHARMACEUTICALS, INC.
$50
DENTSPLY IH AB
$46
Antares Pharma, Inc.
$44
Astellas Pharma US Inc
$41
Endo Pharmaceuticals Inc.
$39
PROCEPT BioRobotics Corporation
$26
Janssen Biotech, Inc.
$26
C. R. Bard, Inc. & Subsidiaries
$26
BIOPROTECT MEDICAL, INC.
$26
Merck Sharp & Dohme LLC
$25
Boston Scientific Corporation
$24
Becton, Dickinson and Company
$17
Olympus America Inc.
$13
Top 3 companies account for 25.2% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$1,482
Endo Pharmaceuticals Inc.
$578
Teleflex LLC
$556
Avadel Specialty Pharmaceuticals, LLC
$530
PFIZER INC.
$530
Antares Pharma, Inc.
$482
Sumitomo Pharma America, Inc.
$316
NeoTract Inc.
$297
Janssen Biotech, Inc.
$286
Tolmar, Inc.
$237
Myriad Genetic Laboratories, Inc.
$221
BOSTON SCIENTIFIC CORPORATION
$218
C. R. Bard, Inc. & Subsidiaries
$206
180 Medical, Inc.
$206
Dendreon Pharmaceuticals LLC
$172
UROVANT SCIENCES INC
$164
Augmenix, Inc.
$156
Laborie Medical Technologies Corp.
$155
ABBVIE INC.
$143
HealthTronics Mobile Solutions, LLC
$130
TOLMAR Pharmaceuticals, Inc.
$127
UroGen Pharma, Inc.
$122
DENTSPLY IH AB
$116
COLOPLAST CORP
$115
AbbVie, Inc.
$111
AbbVie Inc.
$110
Blue Earth Diagnostics Limited
$105
UROGEN PHARMA, INC.
$99
Acerus Pharmaceuticals Corporation
$98
Boston Scientific Corporation
$96
Ferring Pharmaceuticals Inc.
$95
Myovant Sciences Inc.
$79
Endo USA, Inc.
$79
ABC Home Medical Supply, Inc.
$75
ACCORD HEALTHCARE, INC.
$70
Hollister Incorporated
$68
Progenics Pharmaceuticals, Inc.
$66
Mission Pharmacal Company
$62
IMMUNITYBIO, INC.
$59
PROGENICS PHARMACEUTICALS, INC.
$50
Coloplast Corp
$40
Olympus America Inc.
$39
Ethicon US, LLC
$38
Bayer HealthCare Pharmaceuticals Inc.
$32
Kowa Pharmaceuticals America, Inc.
$31
Rochester Medical Corporation
$29
AstraZeneca Pharmaceuticals LP
$28
Amgen Inc.
$27
PROCEPT BioRobotics Corporation
$26
BIOPROTECT MEDICAL, INC.
$26
ConvaTec Inc.
$26
Merck Sharp & Dohme LLC
$25
Otsuka America Pharmaceutical, Inc.
$24
Janssen Scientific Affairs, LLC
$23
Telix Pharmaceuticals
$23
Palette Life Sciences, Inc.
$21
Novartis Pharmaceuticals Corporation
$21
Metuchen Pharmaceuticals
$20
Medtronic USA, Inc.
$19
Axonics Modulation Technologies, Inc.
$19
Axonics, Inc.
$18
Becton, Dickinson and Company
$17
Allergan Inc.
$16
Alnylam Pharmaceuticals Inc.
$15
GENZYME CORPORATION
$13
Valencia Technologies Corporation
$13
Top 3 companies account for 27.5% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AMS · ANKTIVA · AQUABEAM SYSTEM · AVEED · Androgel · Axonics r-SNM System · Axumin · BIOPROTECT BALLOON IMPLANT SYSTEM · BOTOX · BRAC CDx · BRACANALYSIS CDX · Bard Urinary Drainage Bag · Bulkamid · CAMCEVI · CURE CATHETER · CYSTO-NEPHRO VIDEOSCOPE · ECHELON FLEX CST System · ELIGARD · ERLEADA · Erleada · GEMTESA · GENERAL - FEMALE SUI · GENTLECATH · GENTLECATH GLIDE · GREENLIGHT · GentleCath · ILLUCCIX · INTERSTIM · JELMYTO · JEVTANA · JYNARQUE · KEYTRUDA · LOFRIC · LUPRON DEPOT · LYNPARZA · Livalo · LoFric · Lumenis Pulse 120H · Lupron Depot · MAGIC3 · MYRBETRIQ · Mobile Cryoblation Services · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · OTREXUP · OXLUMO · Optilume BPH Drug Coated Balloon Catheter · PROLARIS · PROVENGE · PVC · PYLARIFY · Percutaneous Solutions: PERCUVANCE & MiniLap brands · Prolaris · Prolia · REZUM · SOLYX · SPEEDICATH · Seglentis · Solyx SIS System · SpaceOAR · SpeediCath · Stendra · TOVIAZ · Titan · URIBEL · UROLIFT · Uribel · UroLift · UroLift System · VaPro · VaPro Plus Pocket · XIAFLEX · XTANDI · XYOSTED · Xtandi · eCoin Device Kit · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
214
Per 100K population
37.0
County median income
$84,198
Nearest hospital
GOOD SAMARITAN MEDICAL CENTER
4.2 mi
4.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. McCahill is a clinical cardiology specialist, with above-average Medicare volume (top 7% in MA), with low-engagement industry engagement in the top 17% of MA peers, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. McCahill experienced with infectious disease dna/rna test?
Based on Medicare claims data, Dr. McCahill performed 2,171 infectious disease dna/rna test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. McCahill receive payments from pharmaceutical companies?
Yes. Dr. McCahill received a total of $9,498 from 66 companies across 400 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. McCahill's costs compare to other urology physicians in North Easton?
Dr. McCahill's average Medicare payment per service is $36. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. McCahill) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in North Easton
Browse urology physicians in North Easton ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in MA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in MA
Which MA urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Endo Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Endo Pharmaceuticals Inc.
By company
Teleflex LLC Payments to Doctors
See all physicians who received payments from Teleflex LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology